Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$50.85
*  
0.94
 negative 
1.88%
Get TEVA Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha

Tracking George Soros's Portfolio - Q4 2013 Update
2/18/2014 9:28:00 AM - Seeking Alpha

Pipeline Progress at OncoGenex - Analyst Blog
2/13/2014 5:45:01 PM - Zacks.com

FDA Fully Approves Teva's SYNRIBO For Injection - Quick Facts
2/13/2014 8:39:00 AM - RTT News

Insys Recovers From Stock Hit Tied To Fed Probe
2/12/2014 2:24:00 PM - Investor's Business Daily

Will CoCrystal Discovery (Biozone) Be Dr. Phillip Frost's Next Successful Investment?
2/10/2014 9:05:00 AM - Seeking Alpha

Can Teva's New CEO Turn Its Fortunes Around
2/8/2014 2:40:00 PM - Seeking Alpha

#PreMarket Primer: Friday, February 7: Jobs Friday
2/7/2014 8:16:11 AM - Benzinga

Teva Pharmaceuticals A Giant In Generic Drugs
2/6/2014 6:29:00 PM - Investor's Business Daily

Sector Update: Healthcare Shares Higher Pre-Market; Teva Dips on Q4 Results
2/6/2014 9:55:39 AM - MT Newswires

Sector Update: Healthcares
2/6/2014 9:38:57 AM - MT Newswires

Teva Pharmaceutical Industries Q4 13 Earnings Conference Call At 8:00 AM ET
2/6/2014 8:05:00 AM - RTT News

Teva Q4 Profit Rises, Reaffirms Full Year Forecast - Update
2/6/2014 7:47:00 AM - RTT News

Teva Q4 Results Top View; Backs Full Year Outlook - Quick Facts
2/6/2014 7:19:00 AM - RTT News

Pre-Market Earnings Report for February 6, 2014 : GM, BCE, TEVA, EXC, AET, CMI, NBL, K, PPL, PRGO, NU, ADS
2/5/2014 5:00:03 PM - NASDAQ.com News

A Dividend Growth Portfolio Off The Beaten Path: Q1 2014
2/5/2014 11:59:00 AM - Seeking Alpha

Teva To Price Alexza's New Drug Adasuve At $145 Per Dose In The U.S.
2/4/2014 1:17:00 PM - Seeking Alpha

Teva Pharmaceutical Shares Ready To Break Out In 2014
2/4/2014 12:22:00 PM - Seeking Alpha

A Comprehensive Look At Athersys
2/3/2014 10:12:00 AM - Seeking Alpha

Auspex Pharmaceuticals IPO More Auspicious Than It Sounds
2/3/2014 9:12:00 AM - Seeking Alpha

TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer
1/31/2014 5:18:00 PM - Seeking Alpha

FDA Nod for New Formulation of Teva's Copaxone - Analyst Blog
1/29/2014 6:10:01 PM - Zacks.com

Sector Update: Healthcare Shares Flat Pre-Market; Teva Pharmaceuticals up 4% on FDA Approval for Copaxone
1/29/2014 9:39:05 AM - MT Newswires

Sector Update: Healthcare
1/29/2014 9:38:37 AM - MT Newswires

An Option On Adoption Of A New Multiple Sclerosis Treatment
1/29/2014 8:51:00 AM - Seeking Alpha